CTRI/2018/01/011508
Recruiting
未知
Evaluation of the impact of allele specific gene expression on therapeutic response to oral hypoglycemic drugs in type 2 diabetes - AGED
Science and Engineering Research Board SERB0 sites450 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Type 2 Diabetes
- Sponsor
- Science and Engineering Research Board SERB
- Enrollment
- 450
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically diagnosed drug naïve T2D patients (based on world health organization criteria)
Exclusion Criteria
- •Patients allergic to anti hyperglycemic drugs, type 1 diabetes mellitus, maturity onset diabetes of young (MODYs), gestational diabetes mellitus and secondary diabetes (e.g. pancreatitis, hemochromatosis), clinical renal or hepatic impairment, Cardiac problems (myocardial infarction, unstable angina pectoris), uncontrolled hypertension, non ketotic hyperosmolar coma or chronic diabetic complications, use of medications that could alter glucose metabolism, malignant diseases, hematological diseases, infected with hepatitis virus, psychosis, significant digestion, autoimmune diseases and resorption disturbances acute cerebrovascular accidents within the last 6 months will be excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study on the influence of the key gene phenotype and the effect of qi-supplementing and blood-activating therapy on the therapeutic effect of statins in vascular dementiaVascular DementiaITMCTR2100005177Xiyuan Hospital, Chinese Academy of Traditional Chinese medicine
Recruiting
Not Applicable
Effect of genetic polymorphism on antidiabetic medication in Indian patients with Type 2 DiabetesHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/10/058414Chellaram Diabetes Research Centre
Not yet recruiting
Not Applicable
Heritability in Oropharynx CancerHealth Condition 1: C109- Malignant neoplasm of oropharynx,unspecifiedCTRI/2019/07/020299Department of Health Research
Recruiting
Not Applicable
Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patientson-Small Cell Lung CancerJPRN-UMIN000003723Research institute for diseases of the chest, Kyushu University50
Completed
Phase 3
Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of strokeIschemic strokeJPRN-UMIN000008055Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences1,000